Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
35
RDNT Quote, Financials, Valuation and Earnings
Last price:
$54.78
Seasonality move
:
20.22%
Day range:
$52.39 - $55.55
52-week range:
$45.00 - $85.84
Dividend yield:
0%
P/E ratio:
1,513.25x
P/S ratio:
2.02x
P/B ratio:
3.86x
Volume:
1M
Avg. volume:
927.6K
1-year change:
4.34%
Market cap:
$4.2B
Revenue:
$2B
EPS (TTM):
-$0.26
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RDNT
RadNet, Inc.
|
$553.7M | -$0.18 | 17.46% | -63.92% | $92.38 |
|
CTSO
CytoSorbents Corp.
|
$9.4M | -$0.07 | 7.71% | -41.38% | $5.25 |
|
DCTH
Delcath Systems, Inc.
|
$23.6M | -$0.09 | 19.07% | -44.65% | $21.33 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.06 | 3.03% | 28.53% | $136.11 |
|
ISPC
iSpecimen, Inc.
|
$2.9M | -- | 6.09% | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RDNT
RadNet, Inc.
|
$54.79 | $92.38 | $4.2B | 1,513.25x | $0.00 | 0% | 2.02x |
|
CTSO
CytoSorbents Corp.
|
$0.58 | $5.25 | $38.4M | -- | $0.00 | 0% | 1.00x |
|
DCTH
Delcath Systems, Inc.
|
$9.63 | $21.33 | $337.4M | 154.63x | $0.00 | 0% | 4.45x |
|
ILMN
Illumina, Inc.
|
$127.38 | $136.11 | $19.6B | 23.31x | $0.00 | 0% | 4.58x |
|
ISPC
iSpecimen, Inc.
|
$0.14 | -- | $1.3M | -- | $0.00 | 0% | 0.35x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RDNT
RadNet, Inc.
|
63.04% | 2.041 | 32.11% | 1.65x |
|
CTSO
CytoSorbents Corp.
|
83.14% | 2.188 | 72.52% | 1.49x |
|
DCTH
Delcath Systems, Inc.
|
0.84% | 0.850 | 0.27% | 9.39x |
|
ILMN
Illumina, Inc.
|
48.39% | 1.806 | 12.72% | 1.59x |
|
ISPC
iSpecimen, Inc.
|
8.39% | 4.266 | 2.23% | 0.62x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RDNT
RadNet, Inc.
|
$37.4M | $37.4M | 0.56% | 1.39% | 6.83% | $33.1M |
|
CTSO
CytoSorbents Corp.
|
$6.8M | -$4.1M | -21.56% | -78.59% | -43.87% | -$2.5M |
|
DCTH
Delcath Systems, Inc.
|
$17.7M | -$2.2M | 2.78% | 2.81% | -10.54% | $7.7M |
|
ILMN
Illumina, Inc.
|
$778M | $257M | 16.96% | 35.12% | 22.16% | $263M |
|
ISPC
iSpecimen, Inc.
|
-$555.7K | -$2.8M | -365.92% | -430.7% | -2654.97% | -$3M |
RadNet, Inc. vs. Competitors
-
Which has Higher Returns RDNT or CTSO?
CytoSorbents Corp. has a net margin of 1.8% compared to RadNet, Inc.'s net margin of -59.53%. RadNet, Inc.'s return on equity of 1.39% beat CytoSorbents Corp.'s return on equity of -78.59%.
Company Gross Margin Earnings Per Share Invested Capital RDNTRadNet, Inc.6.83% -$0.01 $3.2B CTSOCytoSorbents Corp.73.68% -$0.09 $35M -
What do Analysts Say About RDNT or CTSO?
RadNet, Inc. has a consensus price target of $92.38, signalling upside risk potential of 68.6%. On the other hand CytoSorbents Corp. has an analysts' consensus of $5.25 which suggests that it could grow by 800.52%. Given that CytoSorbents Corp. has higher upside potential than RadNet, Inc., analysts believe CytoSorbents Corp. is more attractive than RadNet, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RDNTRadNet, Inc.6 0 0 CTSOCytoSorbents Corp.1 1 0 -
Is RDNT or CTSO More Risky?
RadNet, Inc. has a beta of 1.534, which suggesting that the stock is 53.393% more volatile than S&P 500. In comparison CytoSorbents Corp. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.189%.
-
Which is a Better Dividend Stock RDNT or CTSO?
RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. CytoSorbents Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RDNT or CTSO?
RadNet, Inc. quarterly revenues are $547.7M, which are larger than CytoSorbents Corp. quarterly revenues of $9.2M. RadNet, Inc.'s net income of $9.9M is higher than CytoSorbents Corp.'s net income of -$5.5M. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while CytoSorbents Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 2.02x versus 1.00x for CytoSorbents Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RDNTRadNet, Inc.2.02x 1,513.25x $547.7M $9.9M CTSOCytoSorbents Corp.1.00x -- $9.2M -$5.5M
-
Which has Higher Returns RDNT or DCTH?
Delcath Systems, Inc. has a net margin of 1.8% compared to RadNet, Inc.'s net margin of -9.15%. RadNet, Inc.'s return on equity of 1.39% beat Delcath Systems, Inc.'s return on equity of 2.81%.
Company Gross Margin Earnings Per Share Invested Capital RDNTRadNet, Inc.6.83% -$0.01 $3.2B DCTHDelcath Systems, Inc.85.48% -$0.05 $112.2M -
What do Analysts Say About RDNT or DCTH?
RadNet, Inc. has a consensus price target of $92.38, signalling upside risk potential of 68.6%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $21.33 which suggests that it could grow by 121.53%. Given that Delcath Systems, Inc. has higher upside potential than RadNet, Inc., analysts believe Delcath Systems, Inc. is more attractive than RadNet, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RDNTRadNet, Inc.6 0 0 DCTHDelcath Systems, Inc.5 0 0 -
Is RDNT or DCTH More Risky?
RadNet, Inc. has a beta of 1.534, which suggesting that the stock is 53.393% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.439, suggesting its less volatile than the S&P 500 by 56.086%.
-
Which is a Better Dividend Stock RDNT or DCTH?
RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RDNT or DCTH?
RadNet, Inc. quarterly revenues are $547.7M, which are larger than Delcath Systems, Inc. quarterly revenues of $20.7M. RadNet, Inc.'s net income of $9.9M is higher than Delcath Systems, Inc.'s net income of -$1.9M. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while Delcath Systems, Inc.'s PE ratio is 154.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 2.02x versus 4.45x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RDNTRadNet, Inc.2.02x 1,513.25x $547.7M $9.9M DCTHDelcath Systems, Inc.4.45x 154.63x $20.7M -$1.9M
-
Which has Higher Returns RDNT or ILMN?
Illumina, Inc. has a net margin of 1.8% compared to RadNet, Inc.'s net margin of 28.79%. RadNet, Inc.'s return on equity of 1.39% beat Illumina, Inc.'s return on equity of 35.12%.
Company Gross Margin Earnings Per Share Invested Capital RDNTRadNet, Inc.6.83% -$0.01 $3.2B ILMNIllumina, Inc.67.07% $2.17 $5.3B -
What do Analysts Say About RDNT or ILMN?
RadNet, Inc. has a consensus price target of $92.38, signalling upside risk potential of 68.6%. On the other hand Illumina, Inc. has an analysts' consensus of $136.11 which suggests that it could grow by 6.85%. Given that RadNet, Inc. has higher upside potential than Illumina, Inc., analysts believe RadNet, Inc. is more attractive than Illumina, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RDNTRadNet, Inc.6 0 0 ILMNIllumina, Inc.8 7 1 -
Is RDNT or ILMN More Risky?
RadNet, Inc. has a beta of 1.534, which suggesting that the stock is 53.393% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.490, suggesting its more volatile than the S&P 500 by 49.007%.
-
Which is a Better Dividend Stock RDNT or ILMN?
RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RDNT or ILMN?
RadNet, Inc. quarterly revenues are $547.7M, which are smaller than Illumina, Inc. quarterly revenues of $1.2B. RadNet, Inc.'s net income of $9.9M is lower than Illumina, Inc.'s net income of $334M. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while Illumina, Inc.'s PE ratio is 23.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 2.02x versus 4.58x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RDNTRadNet, Inc.2.02x 1,513.25x $547.7M $9.9M ILMNIllumina, Inc.4.58x 23.31x $1.2B $334M
-
Which has Higher Returns RDNT or ISPC?
iSpecimen, Inc. has a net margin of 1.8% compared to RadNet, Inc.'s net margin of -2608.44%. RadNet, Inc.'s return on equity of 1.39% beat iSpecimen, Inc.'s return on equity of -430.7%.
Company Gross Margin Earnings Per Share Invested Capital RDNTRadNet, Inc.6.83% -$0.01 $3.2B ISPCiSpecimen, Inc.-521.3% -$0.48 $3.4M -
What do Analysts Say About RDNT or ISPC?
RadNet, Inc. has a consensus price target of $92.38, signalling upside risk potential of 68.6%. On the other hand iSpecimen, Inc. has an analysts' consensus of -- which suggests that it could grow by 42094.09%. Given that iSpecimen, Inc. has higher upside potential than RadNet, Inc., analysts believe iSpecimen, Inc. is more attractive than RadNet, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RDNTRadNet, Inc.6 0 0 ISPCiSpecimen, Inc.0 0 0 -
Is RDNT or ISPC More Risky?
RadNet, Inc. has a beta of 1.534, which suggesting that the stock is 53.393% more volatile than S&P 500. In comparison iSpecimen, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock RDNT or ISPC?
RadNet, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iSpecimen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet, Inc. pays -- of its earnings as a dividend. iSpecimen, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RDNT or ISPC?
RadNet, Inc. quarterly revenues are $547.7M, which are larger than iSpecimen, Inc. quarterly revenues of $106.6K. RadNet, Inc.'s net income of $9.9M is higher than iSpecimen, Inc.'s net income of -$2.8M. Notably, RadNet, Inc.'s price-to-earnings ratio is 1,513.25x while iSpecimen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet, Inc. is 2.02x versus 0.35x for iSpecimen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RDNTRadNet, Inc.2.02x 1,513.25x $547.7M $9.9M ISPCiSpecimen, Inc.0.35x -- $106.6K -$2.8M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
